Skip to main content

FDA needs to loosen up on CBD but clamp down on quality claims

Enhance consumer protections by establishing product quality-assurance standards, not by restricting access to CBD.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.